Increased Serum Levels of Trypsin Inhibitor Kazal1 in Patients with HBV-Related Hepatocellular Carcinoma Predict a Poor Prognosis.

Saved in:
Bibliographic Details
Title: Increased Serum Levels of Trypsin Inhibitor Kazal1 in Patients with HBV-Related Hepatocellular Carcinoma Predict a Poor Prognosis.
Authors: Yan RR, Zhu T, Wang Q, Yang K, Li J, Guan SH
Source: Clinical laboratory [Clin Lab] 2021 Jan 01; Vol. 67 (1).
Publication Type: Journal Article
Journal Info: Publisher: Clinical Laboratory Publications Country of Publication: Germany NLM ID: 9705611 Publication Model: Print Cited Medium: Internet ISSN: 1433-6510 (Print) Linking ISSN: 14336510 NLM ISO Abbreviation: Clin Lab Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1433-6510
DOI:10.7754/Clin.Lab.2020.200411